Skip to main content
Clinical Trials/CTRI/2024/01/061673
CTRI/2024/01/061673Not yet recruitingPhase 4

Comparative study on the therapeutic efficacy of topical bimatoprost (0.03%) ophthalmic solution and tacrolimus (0.1%) ointment in stable vitiligo. - NI

Eras Lucknow Medical College and Hospital0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Stable vitiligo patients involving less than 5 % of body surface area attending the dermatology OPD at Era Lucknow Medical College and Hospital

Exclusion Criteria

  • 1. Vitiligo patients who took treatment in last 3 months
  • 2. Patient having hypersensitivity to tacrolimus ointment and bimatoprost ophthalmic solution.
  • 3. Pregnant and lactating women

Investigators

Sponsor
Eras Lucknow Medical College and Hospital

Similar Trials

Study on bimatoprost eye solution vs... | Clinical Trial